Хайлтын үр дүнгүүд - David Avigan

Үр дүнг сайжруулах
  1. 1
    Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?

    Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality? -н Jacalyn Rosenblatt, David Avigan

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Vaccine therapy in hematologic malignancies

    Vaccine therapy in hematologic malignancies -н David Avigan, Jacalyn Rosenblatt

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy

    Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy -н Brian Russell, David Avigan

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Dendritic Cell Therapies for Hematologic Malignancies

    Dendritic Cell Therapies for Hematologic Malignancies -н Matthew Weinstock, Jacalyn Rosenblatt, David Avigan

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies

    Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies -н Athalia R. Pyzer, David Avigan, Jacalyn Rosenblatt

    Хэвлэсэн 2014
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death

    Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death -н Yin Li, Turner Kufe, David Avigan, Donald Küfe

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Myeloid‐derived suppressor cells as effectors of immune suppression in cancer

    Myeloid‐derived suppressor cells as effectors of immune suppression in cancer -н Athalia R. Pyzer, Leandra Cole, Jacalyn Rosenblatt, David Avigan

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

    Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells -н Jianlin Gong, David Avigan, Dongshu Chen, Zekui Wu, Shigeo Koido, Masahiro Kashiwaba, Donald Küfe

    Хэвлэсэн 2000
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate

    Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate -н Paul Szabolcs, David Avigan, Stuart Gezelter, DH Ciocon, MA Moore, R M Steinman, James W. Young

    Хэвлэсэн 1996
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses

    Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses -н Mark A. Exley, Syed Muhammad Tahir, Olivia Cheng, Angela Shaulov, Robin Joyce, David Avigan, Robert Sackstein, Steven P. Balk

    Хэвлэсэн 2001
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12

    Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12 -н Jianlin Gong, Shigeo Koido, Dongshu Chen, Yasuhiro Tanaka, Lei Huang, David Avigan, Kenneth C. Anderson, Tsuneya Ohno, Donald Küfe

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy

    Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy -н Chen Tan, Evelyn Bord, Thomas Broge, Brett Glotzbecker, Heidi Mills, Sarah Gheuens, Jacalyn Rosenblatt, David Avigan, Igor J. Koralnik

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity

    Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity -н Jianlin Gong, Najmosama Nikrui, Dongshu Chen, Shigeo Koido, Zekui Wu, Yasuhiro Tanaka, Stephen A. Cannistra, David Avigan, Donald Küfe

    Хэвлэсэн 2000
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

    Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells -н Deepak Raina, Rehan Ahmad, Maya Datt Joshi, Yin Li, Zekui Wu, Takeshi Kawano, Baldev Vasir, David Avigan, Surender Kharbanda, Donald Küfe

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia

    MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia -н Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, Reddy Gali, Maroof Alam, Audrey Bouillez, Surender Kharbanda, Richard M. Stone, David Avigan, Donald Küfe

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    PML targeting eradicates quiescent leukaemia-initiating cells

    PML targeting eradicates quiescent leukaemia-initiating cells -н Keisuke Ito, Rosa Bernardi, Alessandro Morotti, Sahoko Matsuoka, Giuseppe Saglio, Yasuo Ikeda, Jacalyn Rosenblatt, David Avigan, Julie Teruya‐Feldstein, Pier Paolo Pandolfi

    Хэвлэсэн 2008
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    MUC1-C drives MYC in multiple myeloma

    MUC1-C drives MYC in multiple myeloma -н Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, Maroof Alam, Reddy Gali, Shannon T. Bailey, Yu‐Tzu Tai, Teru Hideshima, Kenneth C. Anderson, David Avigan, Donald Küfe

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance

    A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance -н Keisuke Ito, Arkaitz Carracedo, Dror Weiss, Fumio Arai, Ugo Ala, David Avigan, Zachary T. Schafer, Ronald M. Evans, Toshio Suda, Chih‐Hao Lee, Pier Paolo Pandolfi

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: <scp>KEYNOTE</scp>‐013

    Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: <scp>KEYNOTE</scp>‐013 -н Vincent Ribrag, David Avigan, Damian J. Green, Trisha M. Wise‐Draper, Juan G. Posada, Ravi Vij, Ying Zhu, Mohammed Z.H. Farooqui, Patricia Marinello, David S. Siegel

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant

    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant -н Benjamin A. Derman, Jennifer H. Cooperrider, Jacalyn Rosenblatt, David Avigan, Murtuza Rampurwala, David R. Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej Jakubowiak

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: